The Biofluid Inflammometer™ - Advancing Physiologic Measurement to Improve Understanding of Human Disease:

​​

Biofluid Technology, Inc. develops investigational measurement platforms designed to characterize the physical and functional properties of blood and their relationship to human physiology and disease.

​

Many aspects of human disease—particularly those involving inflammation and cardiometabolic dysfunction—are currently assessed through biochemical markers alone. While valuable, these measurements do not directly capture how blood behaves within the circulation or how changes in its properties may affect tissue perfusion and organ function.

Biofluid Technology is developing technologies to address this gap by enabling quantitative characterization of whole blood behavior under physiologically relevant conditions. These platforms are intended to support improved understanding of the relationship between blood flow properties, microcirculatory dynamics, and systemic disease states.

​

Technology Focus:

​

Our work is centered on the development of investigational physiologic measurement systems that:

• Characterize whole blood properties across defined operating conditions

• Generate reproducible, quantitative datasets suitable for analysis

• Support integration with clinical and laboratory data

• Enable future development of data-driven interpretation frameworks

​

Current Development Efforts:

​

Biofluid Technology is currently focused on preclinical validation and risk reduction of its investigational platforms. Ongoing work includes:

• Measurement reproducibility and repeatability assessment

• System performance characterization under controlled conditions

• Evaluation using fresh human whole blood samples

• Refinement of operational and analytical workflows

These efforts are intended to establish a robust technical and translational foundation prior to clinical evaluation.

​

Pipeline:

​

Our current development portfolio includes:

• The Biofluid Inflammometer™ – an investigational whole blood viscometry platform

• Additional technologies under development focused on physiologic measurement and device-based assessment

​

Important Notice:

​

All technologies under development by Biofluid Technology, Inc. are investigational and are not currently approved for diagnostic or clinical use.